Security key
433000106
Hims & Hers Health, Inc. - Common Stock (HIMS)
CUSIP: 433000106
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 148,806,312
- Total 13F value
- $3,077,996,519
- Share change
- -32,747,089
- Put/Call ratio
- 79%
- SEC-reported price per share
- $20.76
- Number of holders
- 431
- Value change
- -$909,943,275
- Number of buys
- 232
- Number of sells
- 264
- Shares outstanding
- 223,329,481
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
431
Top holders
10
HIMS full security history
Ownership snapshot
Full 13F holder table
Hims & Hers Health, Inc. SEC filings
Hims & Hers Health, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of HIMS - Hims & Hers Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Andrew Dudum
Disclosed value leader
Andrew Dudum
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 10%
13D/G row: Andrew Dudum
Showing 1-6 of 15 holder rows.
Quick read
Andrew Dudum leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Andrew Dudum's linked filing trail.
Comparable ownership
Top 5
Andrew Dudum
10%
Capital World Investors
6.5%
SUSQUEHANNA SECURITIES, LLC
6.5%
JPMORGAN CHASE & CO
1.7%
BlackRock, Inc.
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Andrew Dudum |
13D/G
|
10%
|
$1,140,783,140
23,820,905 shares
|
$0 | 07 Aug 2025 |
| Capital World Investors |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$465,068,856
14,322,912 shares
|
— | 31 Dec 2025 |
| SUSQUEHANNA SECURITIES, LLC |
13D/G
G1 Execution Services, LLC
|
6.5%
|
$306,725,654
14,502,395 shares
|
$0 | 31 Mar 2026 |
| JPMORGAN CHASE & CO |
13F
13D/G
Company
|
1.7%
from 13D/G
|
$611,678,662
18,838,270 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
12%
|
$862,841,675
26,573,504 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
9.4%
|
$679,456,374
20,925,666 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
431
Shares
148,806,312
Rows available
431
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
431
Q1 2026 holders
431
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|